Recursion Pharmaceuticals Inc - Class A (RXRX) Company Profile & Statistics

Recursion Pharmaceuticals Inc - Class A
RXRX
(Nasdaq - US)
N/A
7.63
-0.31 (-3.90%)
in:usd•As of: Apr 25, 2024 10:21 UTC -4
Open
7.58
High
7.70
Low
7.48

About Recursion Pharmaceuticals Inc - Class A

CEO

Christopher Gibson

Headquarters

41s rio grande street

salt lake city, ut 84101, united states

Auditor

Ernst & Young LLP

Employees

500

Share Holders

Website

www.recursion.com

Industry

biotechnology

Sector

health technology

Company Overview

Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

Recursion Pharmaceuticals Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	1.81B
Enterprise Value	1.41B
Enterprise Value/EBITDA (ttm)	-4.34
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.89
Price to Sales (ttm)	40.53
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	4.57%
Operating Margin (ttm)	-735.99%
Profit Margin (ttm)	-742.95%
Return on Equity (ttm)	-72.88%
Return on Invested Capital (ttm)	-72.67%
Return on Assets (ttm)	-50.89%

Income Statement

Revenue (ttm)	44.58M
Revenue Per Share (ttm)	0.19
Gross Profit (ttm)	1.99M
EBITDA (ttm)³	-325.66M
Net Income Avi to Common (ttm)	-328.07M
Diluted EPS (ttm)	-1.55

Share Statistics

Beta (5Y Monthly)	0.76
52-Week Change	47.58%
S&P500 52-Week Change	22.75%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	234.65M
Dividend Yield	0.00%
Float ⁴	187.82M
% Held by Insiders	19.96%
% Held by Institutions	89.06%

Balance Sheet

Total Cash (mrq)	394.80M
Total Cash Per Share (mrq)	1.68
Total Debt (mrq)	1.14M
Total Debt/Equity (mrq)	0.25%
Current Ratio (mrq)	4.70%
Quick Ratio (mrq)	4.70%
Book Value Per Share (mrq)	1.98

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.38
Free Cash Flow (ytd)	-299.74M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Recursion Pharmaceuticals Inc - Class A

Trade With A Regulated Broker